LIPOSOMAL BUPIVACAINE
Clinical trials for LIPOSOMAL BUPIVACAINE explained in plain language.
Never miss a new study
Get alerted when new LIPOSOMAL BUPIVACAINE trials appear
Sign up with your email to follow new studies for LIPOSOMAL BUPIVACAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New painkiller may prevent sudden severe pain after shoulder surgery
Symptom relief CompletedThis study tested whether a long-acting form of the painkiller bupivacaine (liposomal bupivacaine) could prevent the sudden, severe pain that often occurs after a shoulder nerve block wears off. 100 adults having shoulder arthroscopy were randomly assigned to receive either lipos…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: PHASE4 • Sponsor: Liu Jiuhong • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New painkiller may ease wisdom tooth recovery better than standard option
Symptom relief CompletedThis study tested whether a long-acting painkiller called Exparel works better than standard bupivacaine for pain after removing all four wisdom teeth. 82 adults took part and reported their pain and side effects for four days after surgery. The goal was to see which drug provide…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: PHASE4 • Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC